(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 1. (A,B) PML is targeted to the nucleolus upon cellular stresses. Confocal images of MRC5 human fibroblasts treated with 35 J/m2 UVC radiation (1 hour), 2 µg/ml doxorubicin (Doxo) for 24 hours, 5 nM actinomycin D (ActD) for 16 hours, 10 µM MG132 for 16 hours, or 10 Gy ionizing radiation
(IR-
) (1 hour). Immunofluorescence was performed using antibodies against PML, B23, fibrillarin or UBF, as indicated. (B) Summary of the localization patterns observed in Pml–/– MEFs expressing PML isoforms -I, -II, -III, -IV or -V, and treated as indicated. NBs, nuclear bodies. (C) PML-I targets nucleolar caps upon doxorubicin treatment. MRC5 cells were transfected with PML-I specific or control siRNA and treated with doxorubicin for 24 hours. Immunofluorescence was then performed using Pan-PML or PML-I-specific sera, as indicated. Nuclei were stained with DAPI.